Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 12, Issue 6, 1997, Pages 1173-1181

  Braun, J ^a   Lindner, K ^a   Schreiber, M ^a   Heidler, R A ^a   Horl W H ^a  

^a KfH Dialysezentrum Nürnberg ^*

Author keywords

Haemodialysis; Hypochromic; Iron supplementation; Red blood cells; rHuEpo; Serum ferritin; Zinc protoporphyrin

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; FERROUS GLUCONATE; HEMOGLOBIN; IRON LECITHIN COMPLEX; PROTOPORPHYRIN ZINC; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY ANEMIA; IRON THERAPY; KIDNEY DISEASE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ZINC BLOOD LEVEL;

ANEMIA, HYPOCHROMIC; ERYTHROCYTE COUNT; ERYTHROPOIETIN; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; PROTOPORPHYRINS; RECOMBINANT PROTEINS; RENAL DIALYSIS;

EID: 0030918074     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.6.1173     Document Type: Article

References (10)

1. Macdougall IC, Cavill I, Hulme B et al. Detection of functional iron deficiency during erythropoietin treatment: a new approach. Br Med J 1992; 304: 225-226
2. Macdougall IC. How to get the best out of rHuEpo. Nephrol Dial Transplant 1995; 10 [Suppl. 2]: 85-91
3. Schaefer RM, Schaefer L. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rHuEpo therapy. J Perinat Med 1995; 23: 83-88
4. Sunder-Plassmann G, Spitzauer S, Hörl WH. The dilemma of evaluating iron status in dialysis patients-limitations of available diagnostic procedures. Nephrol Dial Transplant (in press)
5. Macdougall IC. Monitoring of iron status and iron supplementation in patients treated with erythropoietin. Curr Opin Nephrol Hypertens 1994; 3: 620-625
6. Hastka J, Lassere JJ, Schwarzbeck A, Strauch M, Hehlmann R. Washing erythrocytes to remove interferents in measurement of zinc protoporphyrin by front hematofluorometry. Clin Chem 1992; 38: 2184-2189
7. Braun J, Hammerschmidt M, Schreiber M, Heidler R, Hörl WH. Is zinc protoporphyrin an indicator of iron deficient erythropoiesis in maintenance haemodialysis patients? Nephrol Dial Transplant 1996; 11: 492-497
8. Cavill I. Focus on iron metabolism. In: Iron Forum. Excerpta Medica, Amsterdam, 1996; 1-8
9. Cavill I. Diagnostic methods. Clin Haematol 1982; 11: 259-273
10. Danielson B. R-HuEpo hyporesponsiveness - who and why? Nephrol Dial Transplant 1995; 10 [Suppl. 2]: 69-73